The significance of LOH in TSC1/2 is the subsequent upregulation of mTOR signaling, which is the basis of the action of mTOR inhibitors that are often utilized in PEComa treatment. This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.